These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 9796304)

  • 21. Intravascular detection of the vulnerable plaque.
    Suh WM; Seto AH; Margey RJ; Cruz-Gonzalez I; Jang IK
    Circ Cardiovasc Imaging; 2011 Mar; 4(2):169-78. PubMed ID: 21406663
    [No Abstract]   [Full Text] [Related]  

  • 22. Outcomes associated with the use of secondary prevention medications after coronary artery bypass graft surgery.
    Goyal A; Alexander JH; Hafley GE; Graham SH; Mehta RH; Mack MJ; Wolf RK; Cohn LH; Kouchoukos NT; Harrington RA; Gennevois D; Gibson CM; Califf RM; Ferguson TB; Peterson ED;
    Ann Thorac Surg; 2007 Mar; 83(3):993-1001. PubMed ID: 17307447
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [ACE inhibitors use in patients with acute coronary syndrome].
    Miki T; Kita H; Miura T
    Nihon Rinsho; 1998 Oct; 56(10):2601-6. PubMed ID: 9796325
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Therapeutic measures following acute myocardial infarct: differential use of PTCA, surgery and drugs].
    Noll G; Kaufmann U; Wenzel RR; Lüscher TF
    Schweiz Med Wochenschr; 1996 Feb; 126(5):164-76. PubMed ID: 8685687
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vulnerable plaque: definition, detection, treatment, and future implications.
    Ozer K; Cilingiroglu M
    Curr Atheroscler Rep; 2005 Mar; 7(2):121-6. PubMed ID: 15727727
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The aspect and pathophysiology of acute coronary syndromes].
    Fujii T; Matsuzaki M
    Nihon Rinsho; 1998 Oct; 56(10):2465-70. PubMed ID: 9796303
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of an ongoing educational program on the use of antiplatelet drugs, beta-blockers, angiotensin-converting enzyme inhibitors, and lipid-lowering drugs in patients with coronary artery disease seen in an academic cardiology clinic.
    Nayak D; Aronow WS
    Cardiol Rev; 2005; 13(2):95-7. PubMed ID: 15705260
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Optimal medical management of peripheral arterial disease.
    Rice TW; Lumsden AB
    Vasc Endovascular Surg; 2006; 40(4):312-27. PubMed ID: 16959725
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Imaging of vulnerable plaque].
    Guagliumi G; Musumeci G; Pierli C; Fineschi M; Musuraca AC
    G Ital Cardiol (Rome); 2010 Dec; 11(12 Suppl 3):16S-21S. PubMed ID: 21491735
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acute coronary syndromes: an emphasis shift from treatment to prevention; and the enduring challenge of vulnerable plaque detection in the cardiac catheterization laboratory.
    Valgimigli M; Agostoni P; Serruys PW
    J Cardiovasc Med (Hagerstown); 2007 Apr; 8(4):221-9. PubMed ID: 17413297
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Conservative therapy of acute coronary syndrome in its acute phase and preventive measures].
    Yamaguchi H; Daida H; Sato H; Kurata T; Sakurai H
    Nihon Naika Gakkai Zasshi; 1999 Sep; 88(9):1736-41. PubMed ID: 10581756
    [No Abstract]   [Full Text] [Related]  

  • 32. [CT, MRI for diagnosis of acute coronary syndrome].
    Sato Y; Saito S; Takahashi M
    Nihon Rinsho; 2006 Apr; 64(4):677-85. PubMed ID: 16613184
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Usefulness of optical coherence tomography in the assessment of atherosclerotic culprit lesions in acute coronary syndromes. Comparison with intravascular ultrasound and virtual histology.
    Sukiennik A; Radomski M; Rychter M; Kubica J
    Cardiol J; 2008; 15(6):561-3. PubMed ID: 19039763
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of congestive heart failure in patients with non-ST-segment elevation acute coronary syndromes.
    Roe MT; Chen AY; Riba AL; Goswami RG; Peacock WF; Pollack CV; Collins SP; Gibler WB; Ohman EM; Peterson ED;
    Am J Cardiol; 2006 Jun; 97(12):1707-12. PubMed ID: 16765118
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [From the single vulnerable plaque, to the multiple complex coronary plaques. From their basis, to the modern therapeutic approach. A clinical reality in the spectrum of the acute coronary syndromes].
    Lupi Herrera E; Chuquiure Valenzuela E; Gaspar J; Férez Santander SM
    Arch Cardiol Mex; 2006; 76 Suppl 1():S6-34. PubMed ID: 16830832
    [TBL] [Abstract][Full Text] [Related]  

  • 36. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I.
    Naghavi M; Libby P; Falk E; Casscells SW; Litovsky S; Rumberger J; Badimon JJ; Stefanadis C; Moreno P; Pasterkamp G; Fayad Z; Stone PH; Waxman S; Raggi P; Madjid M; Zarrabi A; Burke A; Yuan C; Fitzgerald PJ; Siscovick DS; de Korte CL; Aikawa M; Juhani Airaksinen KE; Assmann G; Becker CR; Chesebro JH; Farb A; Galis ZS; Jackson C; Jang IK; Koenig W; Lodder RA; March K; Demirovic J; Navab M; Priori SG; Rekhter MD; Bahr R; Grundy SM; Mehran R; Colombo A; Boerwinkle E; Ballantyne C; Insull W; Schwartz RS; Vogel R; Serruys PW; Hansson GK; Faxon DP; Kaul S; Drexler H; Greenland P; Muller JE; Virmani R; Ridker PM; Zipes DP; Shah PK; Willerson JT
    Circulation; 2003 Oct; 108(14):1664-72. PubMed ID: 14530185
    [TBL] [Abstract][Full Text] [Related]  

  • 37. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part II.
    Naghavi M; Libby P; Falk E; Casscells SW; Litovsky S; Rumberger J; Badimon JJ; Stefanadis C; Moreno P; Pasterkamp G; Fayad Z; Stone PH; Waxman S; Raggi P; Madjid M; Zarrabi A; Burke A; Yuan C; Fitzgerald PJ; Siscovick DS; de Korte CL; Aikawa M; Airaksinen KE; Assmann G; Becker CR; Chesebro JH; Farb A; Galis ZS; Jackson C; Jang IK; Koenig W; Lodder RA; March K; Demirovic J; Navab M; Priori SG; Rekhter MD; Bahr R; Grundy SM; Mehran R; Colombo A; Boerwinkle E; Ballantyne C; Insull W; Schwartz RS; Vogel R; Serruys PW; Hansson GK; Faxon DP; Kaul S; Drexler H; Greenland P; Muller JE; Virmani R; Ridker PM; Zipes DP; Shah PK; Willerson JT
    Circulation; 2003 Oct; 108(15):1772-8. PubMed ID: 14557340
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plaque pathology and coronary thrombosis in the pathogenesis of acute coronary syndromes.
    Zhou J; Chew M; Ravn HB; Falk E
    Scand J Clin Lab Invest Suppl; 1999; 230():3-11. PubMed ID: 10389196
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The new paradigm for coronary artery disease: altering risk factors, atherosclerotic plaques, and clinical prognosis.
    O'Keefe JH; Conn RD; Lavie CJ; Bateman TM
    Mayo Clin Proc; 1996 Oct; 71(10):957-65. PubMed ID: 8820770
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adjunctive pharmacologic therapy in percutaneous coronary intervention: part I antiplatelet therapy.
    Kim SJ; Giugliano RP; Jang IK
    Coron Artery Dis; 2011 Mar; 22(1):100-12. PubMed ID: 20926950
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.